SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Heliums rally is being tied primarily to reported adoption by Celina, Texas, where the city is using the Helium networksupporting the broader DePIN and real-world wireless utility narrative. Bullish traders view the development as fuel for continued momentum and a possible short squeeze, while skeptics point to weak hotspot economics, dilution, and management concerns.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A BMF short report questioning the statistical power, control arm, and valuation of SELLASs REGAL Phase 3 AML trial drove attention and selling pressure. Traders remain divided: bears see meaningful downside risk if the trial fails, while bulls dismiss the report and focus on the pending 80th-event announcement and topline readout as potential catalysts.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

A stronger-than-expected quarterly update and higher full-year outlook, combined with broad rotation into healthcare defensives, are driving attention toward Johnson & Johnson. Traders are balancing growth in Innovative Medicine and new products against MedTech softness, patent erosion and lingering talc-related liabilities.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

U.S. tariffs on foreign-made drones and components, alongside anticipated Pentagon spending on domestic drone production, are driving attention to Red Cat as a potential beneficiary. Traders remain divided, with bulls expecting contract awards and Gauntlet II-related momentum, while skeptics point to the lack of confirmed major orders, ongoing losses, dilution, and managements promotional commentary.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck and Modernas personalized mRNA cancer vaccine, used with Keytruda, met key Phase 3 recurrence and metastasis endpoints in resected melanoma, renewing enthusiasm for Mercks oncology pipeline and helping drive the shares to new highs. Traders remain divided over how much of the opportunity is already priced in, with pending full data, regulatory review, manufacturing complexity and Keytrudas eventual patent expiry cited as risks.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

Broad-market diversification and buy-and-hold investing are driving attention, with traders describing VTI as a core portfolio anchor and defensive option amid volatility. Others debate its heavy exposure to mega-cap technology and warn that an AI correction, rising rates, debt concerns, and geopolitical risk could pressure the broader index.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It operates through the following segments: Uranium, Rare Earth Elements (REE), and Heavy Mineral Sands (HMS). The uranium segment engages in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties along with the exploration, permitting and evaluation of uranium properties in the U.S. The REE segment is engaged in the company’s initiatives to progress towards full REE separation capabilities at the Mill to produce both light and heavy separated REE oxides in the coming years. The HMS segment engages in the exploration, development and recovery of HMS at the Kwale Project, Bahia Project, Vara Mada Project and the company’s equity method investments in the Donald Project JV and Tate. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels completed acquisition of Australian Strategic Materials, including the Korean Metals Plant, is fueling discussion about its strategy to build a Western mine-to-magnet rare-earth supply chain alongside its uranium business. Traders are divided between those focused on the strategic minerals, defense and nuclear upside and those frustrated by weak price action, execution risks and profitability concerns.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Treasury Secretary Scott Bessents expanded long-duration Treasury buyback plan is driving attention, with traders speculating it could suppress yields and trigger a short squeeze in TLT. Skeptics argue the intervention is too small to overcome persistent inflation, heavy borrowing and hawkish Fed signals, leaving long-term yieldsand TLTvolatile.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Visas monitoring of Hims & Hers over elevated credit-card disputes tied to its weight-loss subscriptions, alongside ongoing FTC scrutiny, is driving attention and the sharp selloff. Traders disagree on whether the issues are an overblown near-term shock or could force costly changes to the business and weigh on customer confidence, while long-term bulls remain focused on GLP-1, peptide, and telehealth growth.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

A broad biotech rotation and renewed interest in the sectorhighlighted by Moderna and Mercks positive personalized cancer-vaccine datahas driven much of the attention around XBI. Traders remain divided over whether the rally can continue, with higher Treasury yields and rate-hike concerns blamed for sharp pullbacks in the rate-sensitive ETF.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Notable Two Hundred Day Moving Average Cross - COR

In trading on Thursday, shares of Cencora Inc (Symbol: COR) crossed below their 200 day moving average of $323.14, changing hands as low as $321.12 per share. Cencora Inc shares are currently trading off about 1.8% on the day. The chart below shows the one year performance of...

McKesson Raises FY27 Guidance as Oncology and GLP-1 Growth Accelerate

McKesson raises fiscal 2027 EPS guidance as oncology, GLP-1 volumes and specialty distribution drive faster profit growth despite cash-flow pressure.

Is McKesson Stock Worth Buying as Growth Meets a Premium Valuation?

McKesson's double-digit earnings growth, specialty expansion and capital returns support the story, but a premium valuation leaves less room for error.

$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today

Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.61% on an annualized basis producing an average annual return of 19.99%. Currently, Cencora has a market capitalization of $60.51 billion.read more...

Cencora (COR) Q3 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Why Cencora (COR) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Cencora (COR) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why Cencora (COR) is a Strong Growth Stock

Will Pharma and Specialty Demand Boost Cardinal Health's Q4 Results?

Cardinal Health heads into Q4 earnings with pharma, specialty and higher-margin businesses in focus as investors watch if growth offsets pricing headwinds.

COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised

Cencora's fiscal Q3 EPS beats estimates as broad segment growth lifts profit, prompting a higher 2026 outlook despite a slight revenue miss.

• Reported GAAP EPS of $3.95 up 11.27% YoY
• Reported revenue of $84.75B up 5.07% YoY
• Cencora has raised its fiscal year 2026 adjusted diluted EPS guidance to a range of $17.75 to $17.95, reflecting the company's expectations for continued strong full year performance and share repurchases.

Cencora reported rising operating expenses and interest costs due to the OneOncology acquisition, alongside revenue headwinds from manufacturer price declines and the loss of a prior year oncology customer.

Cencora delivered revenue and EPS growth across its segments while executing a $1 billion share repurchase program, demonstrating the strength of the company's pharmaceutical-centric strategy and core business execution.

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Cencora Inc.

Cencora Announces $1B Investment In US After Q4 Numbers Beat Estimates

Equity

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

COR Cencora Inc.

Fundamentals

Connect Stocktwits to ChatGPT

Latest COR News